Return to Home [X]

Exciting News: Introducing the New Essential Evidence Plus!

We are thrilled to announce that a brand-new version of Essential Evidence Plus is on its way! Mark your calendars for the launch date, September 11th, as we are introducing a modern, mobile-first application that will revolutionize your experience. With this update, accessing our valuable content will be easier and more convenient than ever before.

What to Expect from the New Essential Evidence Plus:

  1. Modern Mobile-First Experience: Our new application has been meticulously designed with a mobile-first approach. No matter what device you're using, whether it's a smartphone, tablet, or desktop, you'll enjoy a seamless and intuitive user experience.
  2. Enhanced Accessibility: We understand the importance of accessing content from anywhere, at any time. The new Essential Evidence Plus will provide you with the flexibility to explore our extensive collection of evidence-based resources on the go, making it easier to stay up to date with the latest medical knowledge and interactive tools.
  3. Improved User Interface: We have revamped our user interface to ensure effortless navigation and a visually appealing experience. Finding the information, you need will be quicker and more intuitive, saving you valuable time and effort.

Essential Evidence Plus will be available to users during this transition. However, please note that ability to create new trial and individual subscriptions will not be available from September 8th to September 11th 7:00 AM EST. During this period, we will be working diligently to transfer our existing system to the upgraded platform, ensuring a seamless transition for all users.

We apologize for any inconvenience caused by this temporary interruption. Rest assured, our team is committed to bringing you a superior user experience, and we appreciate your patience and understanding during this time.

Stay Tuned for the New Essential Evidence Plus!

We are counting down the days until September 11th when the new Essential Evidence Plus will be available for you to explore. Get ready to unlock a wealth of evidence-based resources that empower you in your medical decision-making process.

Thank you for your continued support, and we look forward to delivering an exceptional experience with the all-new Essential Evidence Plus!

Essential Evidence Plus

Browse Databases and Tools

Sort by Show per page
  • Cyanoacrylate microbial sealants for skin preparation prior to surgery
    Cochrane Systematic Reviews, 18-May-2016
  • Cyclamen europaeum extract for acute sinusitis
    Cochrane Systematic Reviews, 11-May-2018
  • Cycle regimens for frozen‐thawed embryo transfer
    Cochrane Systematic Reviews, 5-Jul-2017
  • Cycled light in the intensive care unit for preterm and low birth weight infants
    Cochrane Systematic Reviews, 10-Aug-2016
  • Cyclical progestogens for heavy menstrual bleeding
    Cochrane Systematic Reviews, 14-Aug-2019
  • Cycling infrastructure for reducing cycling injuries in cyclists
    Cochrane Systematic Reviews, 10-Dec-2015
  • Cyclobenzaprine for the treatment of myofascial pain in adults
    Cochrane Systematic Reviews, 8-Jul-2009
  • Cyclodestructive procedures for non‐refractory glaucoma
    Cochrane Systematic Reviews, 25-Apr-2018
  • Cyclodestructive procedures for refractory glaucoma
    Cochrane Systematic Reviews, 10-Mar-2019
  • Cyclofenil for Raynaud's phenomenon in progressive systemic sclerosis
    Cochrane Systematic Reviews, 27-Apr-1998
  • Cyclo-oxygenase (COX) inhibitors for preventing preterm labour
    Cochrane Systematic Reviews, 9-Sep-2012
  • Cyclo‐oxygenase (COX) inhibitors for treating preterm labour
    Cochrane Systematic Reviews, 5-Jun-2015
  • Cyclophosphamide for connective tissue disease–associated interstitial lung disease
    Cochrane Systematic Reviews, 3-Jan-2018
  • Cyclophosphamide for multiple sclerosis
    Cochrane Systematic Reviews, 24-Jan-2007
  • Cyclophosphamide for treating rheumatoid arthritis
    Cochrane Systematic Reviews, 23-Oct-2000
  • Cyclophosphamide versus ifosfamide for paediatric and young adult bone and soft tissue sarcoma patients
    Cochrane Systematic Reviews, 30-Sep-2015
  • Cyclophosphamide versus methylprednisolone for treating neuropsychiatric involvement in systemic lupus erythematosus
    Cochrane Systematic Reviews, 28-Feb-2013
  • Cyclosporin A for primary biliary cirrhosis
    Cochrane Systematic Reviews, 18-Jul-2007
  • Cyclosporin as an oral corticosteroid sparing agent in stable asthma
    Cochrane Systematic Reviews, 23-Oct-2000
  • Cyclosporin versus tacrolimus for liver transplanted patients
    Cochrane Systematic Reviews, 18-Oct-2006

Login or Subscribe


Not Yet a Subscriber?

Doctor with handheld

We offer subscriptions for individuals and institutions

To find out about all the benefits of a year-long subscription to Essential Evidence Plus, click the button below!

Learn More